by Natera, Inc.based in USA
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes FDA-approved treatments, novel treatment approaches and ongoing clinical trials targeting found mutations. Unlike any other tumor profiling ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you